results from the ongoing NIH funded Multi-site Multimodality Treatment of Attention Deficit Hyperactivity Disorder (MTA) study (updated in an article this week in the Journal of the American Academy of Child & Adolescent Psychiatry) showed that treatment with the stimulant medication Ritalin (methylphenidate) wasn’t any better than behavioral treatment after two years.